EV/EBITDA
3.98
+0.10+2.58%
89 min ago
Summary
- As of February 21, 2025, CTMX EV/EBITDA is 3.98, with a rise of +0.10 (+2.58%) during the most recent trading day.
- Over the past year, CTMX EV/EBITDA has increased by +26.83 (+117.42%).
- CTMX EV/EBITDA is now -84.75% below its all-time high of 26.09.
Performance
CTMX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTMX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.6% | +2.6% | +1.4% |
| 1 m1 month | -12.1% | -12.1% | -6.8% |
| 3 m3 months | -11.4% | -11.4% | -6.4% |
| 6 m6 months | -53.6% | -47.9% | -34.0% |
| ytdytd | -31.7% | -31.7% | -19.8% |
| 1 y1 year | +117.4% | -65.4% | -45.8% |
| 5 y5 years | +415.9% | -80.6% | -88.9% |
CTMX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.9% | 3.78 | +5.3% | |
| 3 m | 3-month | 8.39 | -52.6% | 3.78 | +5.3% |
| 6 m | 6-month | 9.30 | -57.2% | 3.78 | +5.3% |
| 1 y | 1-year | 26.09 | -84.8% | -42.01 | +109.5% |
| 3 y | 3-year | 26.09 | -84.8% | -42.01 | +109.5% |
| 5 y | 5-year | 26.09 | -84.8% | -42.01 | +109.5% |
| alltime | all time | 26.09 | -84.8% | -42.01 | +109.5% |
CytomX Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 3.98(-31.7%) |
| 2024 | 5.83(-124.0%) |
| 2023 | -24.25(-3666.2%) |
| 2022 | 0.68(-177.3%) |
| 2021 | -0.88(-53.9%) |
| Date | Value |
|---|---|
| 2020 | -1.91(+21.7%) |
| 2019 | -1.57(-72.5%) |
| 2018 | -5.70(-62.3%) |
| 2017 | -15.13(+189.3%) |
| 2016 | -5.23(-75.5%) |
| 2015 | -21.35 |
FAQ
- What is CytomX Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for CytomX Therapeutics?
- What is CTMX EV/EBITDA year-to-date change?
- What is CytomX Therapeutics EV/EBITDA year-on-year change?
What is CytomX Therapeutics EV/EBITDA?
The current EV/EBITDA of CTMX is 3.98
What is the all time high EV/EBITDA for CytomX Therapeutics?
CytomX Therapeutics all-time high EV/EBITDA is 26.09
What is CTMX EV/EBITDA year-to-date change?
CytomX Therapeutics EV/EBITDA has changed by -1.85 (-31.73%) since the beginning of the year
What is CytomX Therapeutics EV/EBITDA year-on-year change?
Over the past year, CTMX EV/EBITDA has changed by +26.83 (+117.42%)